GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curative Biotechnology Inc (OTCPK:CUBT) » Definitions » Policy Acquisition Expense

Curative Biotechnology (Curative Biotechnology) Policy Acquisition Expense


View and export this data going back to 2022. Start your Free Trial

What is Curative Biotechnology Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Curative Biotechnology (Curative Biotechnology) Business Description

Traded in Other Exchanges
N/A
Address
1825 NW Corporate Boulevard, Suite 110, Boca Raton, FL, USA, 33431
Curative Biotechnology Inc is a development-stage biomedical company focusing on novel treatments for rare diseases. The company currently has ongoing programs in three therapeutic areas: Infectious Disease, Neuro-Oncology, and Degenerative Eye Disease.